Joe Swedish, who took the helm of the Indianapolis-based health insurer a month ago, threw cold-water Wednesday on widespread speculation that he will lead the company through a wave of buying hospitals and medical practices.

The Indianapolis pharmaceutical company left its full-year profit forecast unchanged despite a spike in first-quarter earnings. Revenue fell short of analyst expectations.

The Indianapolis-based health insurer easily beat Wall Street's expectations for earnings in the first quarter and revenue rose 15 percent.

A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.

Mercer Marketplace will offer health coverage from four companies—Aetna Inc., Cigna Corp., UnitedHealthcare and Anthem Blue Cross and Blue Shield.

Many investors expect the health care overhaul's coverage expansions to affect WellPoint more than other insurers.

The possibility of thousands of Indiana residents becoming eligible for addiction treatment under the federal health overhaul has state officials and providers preparing for an expansion.

Proponents of a Medicaid expansion in Indiana are playing up the economic boost the state and its businesses could see from the expansion of health insurance coverage called for by President Obama’s health reform law.

Mike Ripley, a health care lobbyist for the Indiana Chamber of Commerce, talked about the business group’s views on a proposed expansion of coverage by the Indiana Medicaid program. As it stands now, the 2013 Indiana budget bill includes a plan passed by the Senate as Senate Bill 551, which would have OK’d the Pence administration to negotiate a block grant deal with the U.S. Department of Health and Human Services to expand Medicaid coverage via a program like the Healthy Indiana Plan. When that bill was altered in the House to remove the block grant concept, the Chamber dropped its support. The altered House bill is now dead, and the original Senate plan has been added to the budget bill. Its ultimate fate is still unknown

Indianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to a new manufacturing plant and improvements to existing operations downtown.

Investor smiles about new experimental cancer drugs and an aggressive play for the animal health market in China turned to frowns after Lilly disclosed deep cuts to its U.S. sales force.

The Indiana University School of Medicine has launched 12 companies in the past 18 months—a burst of startup activity the school has never seen before.

Indiana, Michigan and South Carolina saw the steepest declines in employer-backed coverage from 2000 to 2011, according to a study released Thursday.

The full rollout of Obamacare on Jan. 1 will force some employers to make key decisions this year, but many area experts think 2013 will be anticlimactic, as most employers hold steady to watch the law's changes play out in 2014.

Even as employers embrace workplace wellness and on-site clinics more than ever, there is still a healthy bit of skepticism about whether they actually pay off. But OneAmerica Financial Partners Inc. credits its clinic and wellness program for the lion’s share of a 15-percent reduction in its per-employee costs for health care.

Lawyers for a security company being sued in the theft of $60 million worth of pharmaceuticals from an Eli Lilly and Co. warehouse in Connecticut say there's no proof the thieves used a report it prepared about security weaknesses in the building.

Brian and Emily Kahn had virtually identical physical therapy. He paid much more than she did. Why? Because of where the therapy took place.

The city of Indianapolis is poised to pay Citizens Energy Group $6.5 million to buy a key parcel of real estate it’s targeting as the centerpiece of its ambitious 16 Tech project.

Even though Obamacare likely will expand health insurance coverage to an extra 500,000 Hoosiers over the next few years, IU Health expects per-patient reimbursements to fall as the federal government, employers and patients all push back on sky-high health care costs.

The recent flurry of big announcements portends well.

The statistics we hear so often are clear. As a community, we are not in an enviable place. We smoke more, exercise less and weigh more than the national average, resulting in more diabetes than average.

Fortunately, a Lilly takeover looks less likely today than it has in a long time—for both obvious and more subtle reasons.

The Indianapolis-based health insurer’s board of directors approved higher compensation heading into 2012, after most of its top executives saw their pay hold steady or decline in 2011.

The idea behind the program, which starts in September, is that doctors can no longer leave the business aspect of their jobs to the finance guys while maintaining their integrity as healers.

The compensation paid to outgoing Wellpoint Inc. CEO Angela Braly last year rose 56 percent, even as the company's shares slid on lower enrollment in its Blue Cross Blue Shield health plans.